The Hematologist

168 Episodes

Reverse

One on One With Mary Horowitz

2026-09-0323:33

In this episode contributing editor, Lori Muffly, MD, MS, speaks with a celebrated leader in the field of bone marrow transplantation, Mary Horowitz, MD, MS, of the Medical College of Wisconsin.

A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma

2026-07-2121:32

In this episode, Contributing Editor, Brian Hill, MD, speaks with Juan Alderuccio, MD, of the University of Miami Cancer Center, about a landmark study that supports refined treatment approaches for secondary central nervous system large B-cell lymphoma.

Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

2026-06-1621:00

In this episode, Contributing Editor Meera Sridharan, MD, PhD, speaks with Hiroyuki Matsui, MD, PhD, assistant professor in the department of hematology at Kyoto University Hospital in Japan. Their conversation focuses on the role of narsoplimab in treating a potentially fatal hematologic disorder.

Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?

2026-05-0817:35

In this episode, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD, of Amsterdam University Medical Center in the Netherlands. Their conversation focuses on the potential role of bispecific antibodies in managing patients with Richter transformation.

Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients

2026-04-3020:19

In this episode, Michael Scott, MD, from the University of Toronto, St. Michael’s Hospital, speaks with Samuel Wilson, MD, of the University of North Carolina at Chapel Hill. Their conversation focuses on recent trials examining secondary prevention of venous thromboembolism in higher-risk patients.

#box-pro-ellipsis-178972523397954{-webkit-line-clamp:2;}The Hematologist